Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy (METIV-HCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01755767
Recruitment Status : Completed
First Posted : December 24, 2012
Last Update Posted : February 15, 2019
Sponsor:
Collaborator:
ArQule
Information provided by (Responsible Party):
Daiichi Sankyo, Inc.